Dexin Kong

15PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersMolecular targetsMedical molecular engineering of nucleic acids and proteinsBiofabricationCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 27, 2026
The Antihistamine Astemizole Potentiates the Antitumor Efficacy of Sorafenib in Hepatocellular Carcinoma by Suppressing Proliferation, Metastasis, and Angiogenesis.

|Oct 16, 2025
Pharmacological activation of SIRT6 suppresses progression of head and neck and esophageal squamous cell carcinoma by modulation of cellular metabolism and protein translation.

Talal Ben Lulu, Dinesh Babu Manikandan, Yaniv Pevzner

|May 30, 2025
In Silico Identification and Verification of the Anticancer Mechanism of TMBM-010 from Oxytropis herba with a Rational Delivery System Design.

Zhe Zhang, Hui Zheng, Jindian Fan

|Jun 19, 2024
Sequential Inhibition of PARP and BET as a Rational Therapeutic Strategy for Glioblastoma.

Xin Peng, Xin Huang, Shaolu Zhang

|Dec 19, 2023
A Biomimetic Upconversion Nanobait-Based Near Infrared Light Guided Photodynamic Therapy Alleviates Alzheimer's Disease by Inhibiting β-Amyloid Aggregation.

Xu Wang, Wenjing Zhang, Lili Hou

|Sep 09, 2023
Discovery of a Novel Ubenimex Derivative as a First-in-Class Dual CD13/Proteasome Inhibitor for the Treatment of Cancer.

Jian Zhang, Simin Sun, Jinyu Liu

Pageof 3

Frequent Collaborators

5 joint publications

Moshe Elkabets

2 joint publications

Manu Prasad

2 joint publications

Barak Rotblat

2 joint publications

Xin Peng